Anchiano Therapeutics Ltd. Financial Statements 2011-2024 | ANCN

Annual Financial Statements Anchiano Therapeutics Ltd.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	47.7 M	-	-	-	-	-	-	-	-
Shares	-	37.1 M	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Operating Expenses	11.7 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	7.18 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency